Albaracin, Richard R.

HRN: 26-02-35  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/15/2024
CEFTRIAXONE 1G (VIAL)
10/15/2024
10/22/2024
IV
2g
OD
UTI, Ascariasis
Waiting Final Action 
10/15/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/15/2024
10/22/2024
IV
500mg
Q8
UTI, Ascariasis
Waiting Final Action 
10/16/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/16/2024
10/23/2024
IV
4.5g
Q8
Complicated Uti
Waiting Final Action 
10/26/2024
MEBENDAZOLE 500MG (TAB)
10/26/2024
10/28/2024
PO
500mg
OD
Ascariasis
Waiting Final Action 
11/01/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/01/2024
11/08/2024
IV
4.5g
Q8
Complicated UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: